levofloxacin has been researched along with 8-hydroxyserrulat-14-en-19-oic acid in 1 studies
Studies (levofloxacin) | Trials (levofloxacin) | Recent Studies (post-2010) (levofloxacin) | Studies (8-hydroxyserrulat-14-en-19-oic acid) | Trials (8-hydroxyserrulat-14-en-19-oic acid) | Recent Studies (post-2010) (8-hydroxyserrulat-14-en-19-oic acid) |
---|---|---|---|---|---|
4,346 | 581 | 2,209 | 5 | 0 | 3 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Christo, SN; Griesser, HJ; Hayball, JD; Jasieniak, M; Mon, HH; Ndi, CP; Rickard, H; Semple, SJ | 1 |
1 other study(ies) available for levofloxacin and 8-hydroxyserrulat-14-en-19-oic acid
Article | Year |
---|---|
Serrulatane Diterpenoid from Eremophila neglecta Exhibits Bacterial Biofilm Dispersion and Inhibits Release of Pro-inflammatory Cytokines from Activated Macrophages.
Topics: Animals; Anti-Bacterial Agents; Australia; Biofilms; Cell Survival; Cytokines; Diterpenes; Dose-Response Relationship, Drug; Eremophila Plant; Interleukin-1beta; Interleukin-6; Levofloxacin; Lipopolysaccharides; Macrophages; Mice; Microbial Sensitivity Tests; Molecular Structure; Plants, Medicinal; Scrophulariaceae; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Tumor Necrosis Factor-alpha | 2015 |